Smart Money Hub Free money tools · save your results with a free account
▼ Negative Listen free

Trump raises tariffs on South Korean imports to 25% from 15% over stalled trade deal (Oct 19)

What happened

President Trump announced on Truth Social on Monday that he is increasing U.S. tariffs on South Korean imports — autos, lumber, pharmaceuticals, and all other reciprocal tariffs — from 15% to 25%. He blamed South Korea's National Assembly for failing to enact the "historic" trade deal the two countries sealed in October 2025, under which Seoul pledged roughly $350 billion in U.S. investment in exchange for capped 15% duties. South Korea's presidential office said it had received no formal notification of the hike, and Trade Minister Kim Jung-kwan will head to Washington for emergency talks with Commerce Secretary Howard Lutnick.

Why it matters & what’s next are part of Pro, along with the audio summary.

Start your free 14-day trial

Who’s affected

  • Hyundai Motor / Kia (HYMTF, Korean listings): autos are 27% of South Korea's exports to the U.S., which absorbs nearly half of Korea's car exports; a 25% duty directly hits their U.S. pricing
  • South Korean equities broadly (EWY ETF, KOSPI): KOSPI fell 0.7% and the won weakened 0.5% in early Tuesday trade; the hike puts Korea at a disadvantage vs. Japan and the EU, both at 15%
  • Korean pharma exporters (Samsung Biologics, Celltrion): pharma explicitly named among the targeted sectors
  • U.S. automakers and parts suppliers (GM, Ford): relative beneficiaries if Korean imports face higher duties
  • Lumber importers and U.S. homebuilders: higher lumber costs add to the already depressed housing picture (NAHB sentiment at a 14-year low of 29)
Introducing Paycheck Paradox PRO

Every story is free to read. Pro adds why it matters, what to watch next and audio summaries of every move, hourly.

Start your free 14-day trial

See all the latest moves → · Everything from October 19

Summaries and audio are produced with AI from the linked sources and may contain errors. Not investment advice.